Treatment of cerebral infarcts with anti-oedema agents.
D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives*; D000368:Aged; D001929:Brain Edema / Q000188:drug therapy*; D002544:Cerebral Infarction / Q000188:drug therapy*; D003366:Cosyntropin / Q000627:therapeutic use*; D005990:Glycerol / Q000627:therapeutic use*; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use*; D008875:Middle Aged; D013148:Spironolactone / Q000627:therapeutic use*
D003366:Cosyntropin; D013148:Spironolactone; D000324:Adrenocorticotropic Hormone; D005990:Glycerol; D008775:Methylprednisolone